Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Equity Ratio (2016 - 2025)

IGC Pharma (IGC) has disclosed Equity Ratio for 15 consecutive years, with 0.83 as the latest value for Q3 2025.

  • Quarterly Equity Ratio rose 16.74% to 0.83 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.83 through Sep 2025, up 16.74% year-over-year, with the annual reading at 0.72 for FY2025, 2.12% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.83 at IGC Pharma, up from 0.77 in the prior quarter.
  • The five-year high for Equity Ratio was 0.94 in Q4 2021, with the low at 0.69 in Q4 2024.
  • Average Equity Ratio over 5 years is 0.84, with a median of 0.85 recorded in 2023.
  • The sharpest move saw Equity Ratio fell 16.7% in 2024, then rose 16.74% in 2025.
  • Over 5 years, Equity Ratio stood at 0.94 in 2021, then fell by 3.12% to 0.91 in 2022, then fell by 11.9% to 0.8 in 2023, then decreased by 14.25% to 0.69 in 2024, then rose by 20.46% to 0.83 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.83, 0.77, and 0.72 for Q3 2025, Q2 2025, and Q1 2025 respectively.